Goldman Sachs’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-17,336
| Closed | -$37K | – | 4482 |
|
|
2017
Q3 | $37K | Sell |
17,336
-75
| -0.4% | -$160 | ﹤0.01% | 4151 |
|
|
2017
Q2 | $50K | Sell |
17,411
-18,380
| -51% | -$52.8K | ﹤0.01% | 4246 |
|
|
2017
Q1 | $123K | Sell |
35,791
-16,594
| -32% | -$57K | ﹤0.01% | 4069 |
|
|
2016
Q4 | $91K | Buy |
52,385
+18,328
| +54% | +$31.8K | ﹤0.01% | 4123 |
|
|
2016
Q3 | $113K | Sell |
34,057
-8,159
| -19% | -$27.1K | ﹤0.01% | 4148 |
|
|
2016
Q2 | $182K | Sell |
42,216
-14,134
| -25% | -$60.9K | ﹤0.01% | 3908 |
|
|
2016
Q1 | $317K | Sell |
56,350
-4,523
| -7% | -$25.4K | ﹤0.01% | 3514 |
|
|
2015
Q4 | $1.05M | Sell |
60,873
-18,881
| -24% | -$325K | ﹤0.01% | 2869 |
|
|
2015
Q3 | $1.68M | Sell |
79,754
-3,141
| -4% | -$66.2K | ﹤0.01% | 2638 |
|
|
2015
Q2 | $4.1M | Buy |
82,895
+57,886
| +231% | +$2.87M | ﹤0.01% | 2180 |
|
|
2015
Q1 | $1.96M | Sell |
25,009
-44,080
| -64% | -$3.45M | ﹤0.01% | 2547 |
|
|
2014
Q4 | $4.19M | Sell |
69,089
-36,460
| -35% | -$2.21M | ﹤0.01% | 2088 |
|
|
2014
Q3 | $4.5M | Buy |
105,549
+82,004
| +348% | +$3.49M | ﹤0.01% | 2044 |
|
|
2014
Q2 | $1.46M | Buy |
23,545
+17,721
| +304% | +$1.1M | ﹤0.01% | 2741 |
|
|
2014
Q1 | $378K | Sell |
5,824
-4,403
| -43% | -$286K | ﹤0.01% | 3542 |
|
|
2013
Q4 | $576K | Sell |
10,227
-42,958
| -81% | -$2.42M | ﹤0.01% | 3354 |
|
|
2013
Q3 | $3.26M | Buy |
53,185
+45,032
| +552% | +$2.76M | ﹤0.01% | 2195 |
|
|
2013
Q2 | $477K | Buy |
+8,153
| New | +$477K | ﹤0.01% | 3191 |
|